Cactus Life Sciences’ Post

Many medical affairs teams want to measure their impact but focusing too much on activities rather than outcomes. To drive real change, it’s essential to commit to outcomes that truly matter, like increasing awareness of unmet medical needs or presenting data that challenges current clinical practices. At Acceleration Point, our Accelerated Insights program is designed to help teams define, measure, and align their work toward achieving those impactful outcomes. Let us help you commit to medical impact! Learn more here: 👉 https://lnkd.in/e5AvRCJ8  #MedicalAffairs #Insights #pharmainnovation #Pharma #Kwello

This past week, I had the privilege of discussing the importance of medical information within the life sciences industry with a group of pharmacy students. One key aspect we touched on is how unsolicited medical inquiries are handled through Medical Information Request Forms (MIRF). • What is a MIRF? A standardized form used by healthcare professionals to request specific information about a drug or device that may not be readily available in the prescribing information. It’s a crucial tool in facilitating accurate, unbiased medical communication. • Purpose & Use MIRFs streamline the process of providing critical information to healthcare professionals, ensuring they have access to the most current and reliable data to inform patient care decisions. • Technology & MIRFs Today, platforms supporting MIRFs have enhanced their efficiency, making it easier to submit, track, and manage requests. This ensures healthcare professionals receive timely responses while maintaining transparency in communication. MIRFs are more than just a form—they are essential for bridging the gap between the pharmaceutical industry and healthcare providers, ensuring that the right information reaches the right hands when it’s needed most. #LifeSciences #Pharma #Biotech —————— 🔔 Follow me here on LinkedIn for clear, concise insights into the life sciences. I post three times weekly! 📩 Subscribe to my monthly newsletter for deeper dives into topics important to the medical information space.

Discover how to leverage the new impact metrics that matter for journal selection with Altmetric's latest whitepaper. 🔛A comprehensive guide designed for publication planners and communication teams in medical affairs and pharma, helping you stay ahead of the curve and improve your publication strategy. Download it now!🔗 https://lnkd.in/g_G_ZJAm

The Power of Scoping Reviews in Medical Affairs Strategic Insights with Comprehensive Evidence Mapping In the fast-paced world of pharmaceuticals, staying ahead of the curve is crucial. Medical Affairs teams are at the heart of ensuring that clinical data is translated into actionable insights. But how do you keep up with the ever-evolving landscape of medical research? The answer lies in Scoping Reviews. At Clinical Insights, we specialize in conducting thorough scoping reviews that provide your Medical Affairs team with a comprehensive understanding of the existing evidence base. Our reviews map out the entire research landscape, helping you identify key trends, knowledge gaps, and opportunities to enhance your product’s clinical positioning. Why choose Clinical Insights? 🔍 Comprehensive Evidence Mapping – We ensure no stone is left unturned. 📊 Actionable Insights – Translate data into strategic decisions. 📈 Stay Competitive – Ensure your strategies are informed by the latest research. https://lnkd.in/dR2nPXJh #MedicalAffairs #Pharma #ScopingReview #ClinicalInsights #EvidenceBasedMedicine

Disruptions in Pharma? Suhail Ali of ICON plc Shares Secrets to Thrive! ✨ The ever-changing pharmaceutical landscape can be a nightmare for clinical trials. But what if you could not only weather disruptions but turn them into opportunities? Suhail shares: 💊 How to navigate the high-stakes world of regulatory compliance 💊 Strategies to mitigate crises and ensure successful medicinal delivery 💊 The power of technology in futureproofing your clinical trials Don't miss out on these game-changing insights! Watch the full interview now! ⬇ #pharmaceutical #drugdevelopment #clinicaltrials #thoughtleadership #healthcare #lifescience #medtech #regulatoryaffairs #compliance 

In our webinar, "Medical, reimagined: How technology-driven insights can help us rethink strategy and execution," we engaged with participants to explore their perspectives on the technology advancements in healthcare. We delved into the challenges they encounter while integrating new technologies into medical affairs to create a more efficient, effective, and inspiring scientific future for pharma.   Discover our report and contact us for the webinar recording 👉 bais@envisionpharma.com.

🚀 Is inefficient MLR draining your resources and compromising your objectives? Join Impatient Health’s webinar, "The Real Cost of MLR,” delving into strategies to improve efficiency and maximize the value of MLR processes. Jimmie Overton, one of Canopy’s Medical Affairs experts, will be part of Impatient Health’s panel of industry experts discussing: ✅ New data revealing MLR’s true impact on organizational function ✅ Challenges of scaling to manage increasing content volume and complexity ✅ Strategies to structure, optimize, and elevate Medical’s contribution to the MLR team You’ll gain insights into: • Effective ways to structure and amplify Medical’s role within MLR • Solutions that enable your team to focus on core strategic objectives • Scalable approaches to enhance the efficiency and impact of the medical review process Don’t miss this opportunity to uncover hidden truths about MLR and take steps toward a more impactful approach. 📅 Thursday October 31st, 2024 3:00pm London / 4:00pm Paris / 11:00am New York/ 8:00am San Francisco ⏱️1 hour 🖥️ Zoom Register now: https://bit.ly/3UkvnHM #MedicalAffairs #MLR #Pharmaceuticals #Biotech #ImpatientHealth

Empower Your Regulatory Knowledge with Medscape's Resources! - Latest Clinical Guidelines: Stay aligned with up-to-date, evidence-based practices. - Extensive Drug Information: Access details on over 7,000 drugs, including interactions and contraindications. - Advanced Medical Tools: Utilize tools like the drug interaction checker and pill identifier for informed decision-making. - Comprehensive Diseases & Conditions Database: Get insights with over 6,000 articles on various conditions. - Interactive Learning and Simulations: Engage with patient simulations, quizzes, and case studies. #RegulatoryAffairs #Pharmaceuticals #ClinicalGuidelines #DrugInformation #MedicalTools #HealthcareInnovation #Medscape

Objective measurement of Medical Affairs impact. How do your measure you share of scientific voice and share of digital voice to impact strategic imperatives? Learn more in the below article from MAPS or speak to our Medical Affairs specialist today https://lnkd.in/eTYg8BvH #strategic #measurment #impact #medicalaffairs #measure #industry #medical #topic #digital #demonstrate

🔬 #RegulatoryInsights: Anatomy of an FDA Clinical Hold Ever wonder what happens when the FDA hits pause on a clinical trial? Let me break it down through a recent scenario: Case Study: Imagine BioTech X's promising immunotherapy candidate got placed on clinical hold last quarter. Here's how the process unfolded: 📱 Day 0: FDA initiated an urgent teleconference with BioTech X's clinical team, citing safety concerns about their novel delivery mechanism 📋 Day 28: Official clinical hold letter arrived, signed by the Division Director, detailing: 1. Primary concerns about the delivery system's potential neurological effects 2. Required modifications to the safety monitoring protocol 3. Clear separation between hold issues and additional recommendations ⚡ The key rule: No patient enrollment could continue until FDA explicitly greenlit the trial's resumption. BioTech X's Response Playbook: Assembled a cross-functional task force Modified the delivery system based on FDA's concerns Enhanced safety monitoring protocols Submitted a comprehensive response package ⏰ Important Timeline Note: FDA must respond within 30 days of receiving a COMPLETE response. Partial fixes don't start the clock! 💡 Pro Tip: Keep your FDA contact (named in the hold letter) in the loop. Clear communication can make or break your timeline to resolution. #regulatory #regulatoryaffairs #submissionmanagement #publishing #pharma #biotech #knowledgeshare #CMC #FDA #EMA #regulatoryinsights